High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa. Jiang SW, Kwock JT, Liu B, Petty AJ, et al. Br J Dermatol 2022;187:417-419.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang SW, Kwock JT, Liu B, Petty AJ, et al. High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa. Br J Dermatol 2022;187:417-419.
PMID: 35192196